BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb operating income 1987–2026

Bristol-Myers Squibb's operating income in Q3 FY2026, the three months to 30 September 2026, was 2.84B USD, down 21.9% on the same quarter a year before. Bristol-Myers Squibb's operating income over the last twelve months was 13.05B USD, up 14.2% on the twelve months before. In fiscal year 2025 it was 13.72B USD, up 133.1% on the year before.

Last updated 12 Nov 2026 · Next report 4 Feb 2027

Operating income

Operating income · +23.0% a year over 10 yearsOperating margin

Growth

Fiscal yearPeriod endingOperating incomeGrowthOperating marginGross profitGross marginEBITDA
TTM30 Sept 202613.05B+14.24%26.07%34.64B69.24%15.15B
FY202531 Dec 202513.72B+133.12%28.48%34.26B71.08%15.23B
FY202431 Dec 20245.89B-28.16%12.19%34.33B71.08%3.17B
FY202331 Dec 20238.20B-9.98%18.21%34.31B76.24%19.37B
FY202231 Dec 20229.10B+6.64%19.72%36.02B78.04%19.22B
FY202131 Dec 20218.54B+292.15%18.40%36.45B78.57%20.12B
FY202031 Dec 20202.18B-63.18%5.12%30.75B72.31%4.93B
FY201931 Dec 20195.91B+15.62%22.62%18.07B69.10%7.38B
FY201831 Dec 20185.11B+48.40%22.67%16.09B71.34%6.79B
FY201731 Dec 20173.45B-22.86%16.59%14.76B71.05%6.12B
FY201631 Dec 20164.47B+158.21%22.99%14.46B74.42%6.46B
FY201531 Dec 20151.73B+0.93%10.45%12.65B76.39%2.64B
FY201431 Dec 20141.71B-41.52%10.79%11.95B75.24%3.05B
FY201331 Dec 20132.93B-25.46%17.89%11.77B71.81%3.85B
FY201231 Dec 20123.93B-40.76%22.31%13.01B73.84%3.20B
FY201131 Dec 20116.64B+11.55%31.24%15.65B73.65%7.75B
FY201031 Dec 20105.95B+9.40%30.54%14.21B72.92%6.82B
FY200931 Dec 20095.44B+8.28%28.92%13.67B72.67%6.49B
FY200831 Dec 20085.02B+42.38%24.39%12.40B60.20%5.90B
FY200731 Dec 20073.53B+47.86%18.23%13.13B67.86%4.42B
FY200631 Dec 20062.39B-36.15%13.32%11.52B64.29%3.31B
FY200531 Dec 20053.74B-16.29%19.46%12.87B67.00%4.67B
FY200431 Dec 20044.46B-9.51%23.03%13.39B69.10%5.37B
FY200331 Dec 20034.93B+20.29%23.61%13.25B63.40%5.72B
FY200231 Dec 20024.10B-20.49%22.63%11.57B63.88%4.84B
FY200131 Dec 20015.16B-13.83%26.56%12.53B64.53%5.89B
FY200031 Dec 20005.99B+14.26%32.86%13.46B73.87%6.73B
FY199931 Dec 19995.24B+17.57%25.91%13.01B64.36%5.92B
FY199831 Dec 19984.46B+0.41%24.37%11.79B64.48%5.08B
FY199731 Dec 19974.44B+12.27%26.57%12.83B76.81%5.03B
FY199631 Dec 19963.95B+9.35%26.24%11.62B77.13%4.47B
FY199531 Dec 19953.62B+12.23%26.26%10.58B76.84%4.06B
FY199431 Dec 19943.22B+34.04%26.88%9.19B76.69%3.55B
FY199331 Dec 19932.40B+22.60%21.05%8.69B76.16%2.71B
FY199231 Dec 19921.96B-29.14%17.57%8.59B77.03%2.26B
FY199131 Dec 19912.77B+15.78%24.79%8.48B75.95%3.01B
FY199031 Dec 19902.39B+120.59%23.19%7.67B74.47%2.63B
FY198931 Dec 19891.08B-38.81%11.79%6.73B73.23%1.28B
FY198831 Dec 19881.77B+20.65%20.68%6.26B73.14%1.96B
FY198731 Dec 19871.47B—19.41%5.42B71.67%1.63B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about Bristol-Myers Squibb's operating income

Source: Financial Modeling PrepVerified against SEC filings